BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 28668085)

  • 21. Treatment of chronic immune-mediated neuropathies: chronic inflammatory demyelinating polyradiculoneuropathy, multifocal motor neuropathy, and the Lewis-Sumner syndrome.
    Sederholm BH
    Semin Neurol; 2010 Sep; 30(4):443-56. PubMed ID: 20941678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sensory chronic inflammatory demyelinating polyneuropathy: an under-recognized entity?
    Ayrignac X; Viala K; Koutlidis RM; Taïeb G; Stojkovic T; Musset L; Léger JM; Fournier E; Maisonobe T; Bouche P
    Muscle Nerve; 2013 Nov; 48(5):727-32. PubMed ID: 23424105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment options for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)].
    Kuntzer T
    Rev Neurol (Paris); 2006 Apr; 162(4):539-43. PubMed ID: 16585918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Modern aspects of diagnosis and treatment of chronic inflammatory demyelinating polyneuropathy in children].
    Kozyreva AA; Bembeeva RT; Druzhinina ES; Zavadenko NN; Kolpakchi LM; Pilia SV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(2):58-68. PubMed ID: 38465811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Longer-term effects of intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: Who benefits?
    Terhoeven P; Seybold J; Utz KS; Nickel FT; Lee DH; Linker RA
    J Neurol Sci; 2020 Dec; 419():117169. PubMed ID: 33035867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous immunoglobulin response in treatment-naïve chronic inflammatory demyelinating polyradiculoneuropathy.
    Kuitwaard K; Hahn AF; Vermeulen M; Venance SL; van Doorn PA
    J Neurol Neurosurg Psychiatry; 2015 Dec; 86(12):1331-6. PubMed ID: 25515502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies.
    Merkies ISJ; van Schaik IN; Léger JM; Bril V; van Geloven N; Hartung HP; Lewis RA; Sobue G; Lawo JP; Durn BL; Cornblath DR; De Bleecker JL; Sommer C; Robberecht W; Saarela M; Kamienowski J; Stelmasiak Z; Tackenberg B; Mielke O;
    J Peripher Nerv Syst; 2019 Mar; 24(1):48-55. PubMed ID: 30672091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosis and treatment response in the asymmetric variant of chronic inflammatory demyelinating polyneuropathy.
    Lucke IM; Wieske L; van der Kooi AJ; van Schaik IN; Eftimov F; Verhamme C
    J Peripher Nerv Syst; 2019 Jun; 24(2):174-179. PubMed ID: 31090121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Therapeutic strategy for CIDP (chronic inflammatory demyelinating polyneuropathy)].
    Iijima M; Koike H; Sobue G
    Nihon Rinsho; 2013 May; 71(5):855-60. PubMed ID: 23777094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Segmental somatosensory-evoked potentials as a diagnostic tool in chronic inflammatory demyelinating polyneuropathies, and other sensory neuropathies.
    Koutlidis RM; Ayrignac X; Pradat PF; Le Forestier N; Léger JM; Salachas F; Maisonobe T; Fournier E; Viala K
    Neurophysiol Clin; 2014 Sep; 44(3):267-80. PubMed ID: 25240560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and economic comparison of an individualised immunoglobulin protocol vs. standard dosing for chronic inflammatory demyelinating polyneuropathy.
    Rajabally YA; Afzal S
    J Neurol; 2019 Feb; 266(2):461-467. PubMed ID: 30556098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Motor unit number index (MUNIX) in chronic inflammatory demyelinating polyneuropathy: A potential role in monitoring response to intravenous immunoglobulins.
    Lawley A; Seri S; Rajabally YA
    Clin Neurophysiol; 2019 Oct; 130(10):1743-1749. PubMed ID: 31400577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Childhood chronic inflammatory demyelinating polyneuroradiculopathy--three cases and a review of the literature.
    Riekhoff AG; Jadoul C; Mercelis R; Cras P; Ceulemans BP
    Eur J Paediatr Neurol; 2012 Jul; 16(4):315-31. PubMed ID: 22225859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunomodulation of inflammatory leukocyte markers during intravenous immunoglobulin treatment associated with clinical efficacy in chronic inflammatory demyelinating polyradiculoneuropathy.
    Dyer WB; Tan JC; Day T; Kiers L; Kiernan MC; Yiannikas C; Reddel S; Ng K; Mondy P; Dennington PM; Dean MM; Trist HM; Dos Remedios C; Hogarth PM; Vucic S; Irving DO
    Brain Behav; 2016 Oct; 6(10):e00516. PubMed ID: 27781132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical spectrum, treatment and outcome of children with suspected diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy.
    Silwal A; Pitt M; Phadke R; Mankad K; Davison JE; Rossor A; DeVile C; Reilly MM; Manzur AY; Muntoni F; Munot P
    Neuromuscul Disord; 2018 Sep; 28(9):757-765. PubMed ID: 30072201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic inflammatory demyelinating polyradiculoneuropathy presenting as cauda equina syndrome in a diabetic.
    Lai WW; Ubogu EE
    J Neurol Sci; 2007 Sep; 260(1-2):267-70. PubMed ID: 17521674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous immunoglobulin and intravenous methylprednisolone as optimal induction treatment in chronic inflammatory demyelinating polyradiculoneuropathy: protocol of an international, randomised, double-blind, placebo-controlled trial (OPTIC).
    Bus SRM; Zambreanu L; Abbas A; Rajabally YA; Hadden RDM; de Haan RJ; de Borgie CAJM; Lunn MP; van Schaik IN; Eftimov F;
    Trials; 2021 Feb; 22(1):155. PubMed ID: 33608058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two cases of chronic immune sensorimotor polyradiculopathy: Expanding the spectrum of chronic immune polyradiculopathies.
    Khadilkar S; Patel B; Mansukhani KA; Jaggi S
    Muscle Nerve; 2017 Jan; 55(1):135-137. PubMed ID: 27530499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. A double-blind, placebo-controlled, cross-over study.
    Hahn AF; Bolton CF; Zochodne D; Feasby TE
    Brain; 1996 Aug; 119 ( Pt 4)():1067-77. PubMed ID: 8813271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of mycophenolate mofetil in patients with chronic immune demyelinating polyneuropathy.
    Gorson KC; Amato AA; Ropper AH
    Neurology; 2004 Aug; 63(4):715-7. PubMed ID: 15326250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.